Bank of America: Analysts' Upgrades, Downgrades

BAC target, estimates lifted at Citi, Barclays and UBS.
Author:
Publish date:

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Advance Auto Parts

(AAP) - Get Report

numbers raised at Goldman. Shares of AAP now seen reaching $49. Estimates also increased, given higher buyback activity. Neutral rating.

Advance Auto Parts

(AAP) - Get Report

downgraded at UBS from Buy to Neutral. $49 price target. Stock has outperformed its peers and the company is facing difficult comps in a period that saw adverse weather conditions.

Abovenet

(ABVT)

upgraded at Wells from Market Perform to Outperform. Recent pullback has created an attractive buying opportunity.

Allergan

(AGN) - Get Report

upgraded at Goldman from Neutral to Buy. Stock was also added to the Conviction Buy list, as the company has exposure to the aging and obesity markets.

AK Steel

(AKS) - Get Report

downgraded at Longbow from Buy to Neutral. Estimates also lowered, as the company faces higher iron ore prices.

Continental Resources

(CLR) - Get Report

downgraded at UBS from Buy to Neutral. Valuation call, based on a $50 price target.

Cognizant Technology

(CTSH) - Get Report

downgraded at Goldman from Buy to Neutral. Valuation call, based on a $57 price target. Even so, estimates were raised, because of higher sales expectations.

Endo Pharmaceuticals

(ENDP) - Get Report

upgraded at Goldman from Neutral to Buy. Valuation call, as earnings should come in ahead of consensus expectations.

First Horizon National

(FHN) - Get Report

numbers increased at Barclays. FHN price target raised by a dollar to $15 after better than expected 1Q10. 2010 and 2011 EPS estimates improved to -$0.25 and $0.50, respectively. Maintain Equal Weight rating.

Forest Oil

(FST)

upgraded at Goldman from Neutral to Buy. Stock was also added to the Conviction List, as the stock has lagged since the company's analyst meeting. $34 price target.

King Pharmaceuticals

(KG)

downgraded at Goldman from Outperform to Sell. See slowing growth and the need for the company to boost spending.

Lincoln Electric

(LECO) - Get Report

upgraded at Piper Jaffray. Rating raised to Overweight from Neutral. Price target raised to $70 from $55. 2010 EPS estimates raised to $2.65 from $2.50.

Lifepoint Hospitals

(LPNT)

downgraded at Goldman from Neutral to Sell. Valuation call, given the company's exposure to rural hospitals.

Lender Processing

(LPS)

upgraded at Goldman from Neutral to Buy. Estimates also boosted, as the default cycle should remain strong. $48 price target.

Mohawk

(MHK) - Get Report

upgraded at Suntrust from Neutral to Buy. $80 price target. Company is seeing higher U.S. demand and is raising prices.

Medicis Pharmaceutical

(MRX)

downgraded at Goldman from Buy to Neutral. Valuation call, based on a $28 price target.

Pool Corporation

(POOL) - Get Report

upgraded at Piper Jaffray. Rating raised to Neutral from Underweight. Price target raised to $21 from $17. 2010 EPS estimates raised to $1.07 from $1.05.

Sprint-Nextel

(S) - Get Report

upgraded at Wells to Outperform. Channel checks show that the company is seeing positive customer trends.

Suntech Power

(STP)

upgraded at ThinkEquity from Sell to Hold. Estimates also boosted, as Germany will likely not cap solar subsidies.

Safeway

(SWY)

downgraded at Credit Suisse to Neutral from Outperform on valuation. Price target maintained at $27. 2010 and 2011 EPS estimates held at $1.75 and $2.05, respectively.

T Rowe Price

(TROW) - Get Report

upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $67 from $66. 2010 EPS estimates raised to $2.72 from $2.70.

TW Telecom

(TWTC)

downgraded at Wells from Outperform to Market Perform. Valuation call, as the stock is up 17% in the past 2 months.

Universal Health

(UHS) - Get Report

upgraded at Goldman from Sell to Neutral. Estimates also boosted, because of lower bad-debt costs. $36 price target.

STOCK COMMENTS / EPS CHANGES

Apple

(AAPL) - Get Report

estimates, target boosted at Kaufman. Shares now seen reaching $305. Estimates also increased, as the company will likely sell more iPhones. Buy rating.

Apache

(APA) - Get Report

target cut, estimates higher at Barclays. APA price target trimmed by a dollar to $131 after the company announced a merger with Mariner Energy. 2010 and 2011 EPS estimates lifted to $9.40 and $9.70, respectively. Reiterate Overweight rating.

Atmel

(ATML)

estimates, target raised at FBR. Shares of ATML now seen reaching $6. Estimates also increased, following strong channel checks. Outperform rating.

Bank of America

(BAC) - Get Report

target, estimates lifted at Citi to $26 from $23 on 1Q10 results. Core PTPP shows strength in trading. 2010 EPS estimates increased to $0.95, 2011 held at $2.00. Maintain Buy rating.

Bank of America

(BAC) - Get Report

target, estimates higher at Barclays by a dollar to $21 following decent 1Q10 results. Credit outlook good. 2010 and 2011 EPS estimates improved to $1.15 and $1.90, respectively. Equal Weight rating.

Bank of America

(BAC) - Get Report

estimates, target upped at UBS. Shares of BAC now seen reaching $21. Estimates also boosted, as the company is seeing better sales and credit trends. Buy rating.

Ciena

(CIEN) - Get Report

target raised at UBS to $18. Company has a favorable product cycle and expect a positive upcoming analyst meeting. Neutral rating.

Cummins

(CMI) - Get Report

target, estimates higher at Credit Suisse. CMI price target surged to $84 from $68. 2011 and 2012 EPS estimates jumped to $4.25 and $6.00, respectively. Emerging markets still on fire. Reiterate Outperform.

Coach

(COH)

estimates boosted at UBS through 2011. Company is seeing higher sale growth. Neutral rating and $39 price target.

Dell

(DELL) - Get Report

target, estimates boosted at Barclays. DELL price target raised by a dollar to $17 as PC sales forecast was lifted. 2011 and 2012 EPS estimates increased to $1.27 and $1.42, respectively. Maintain Equal Weight rating.

General Electric

(GE) - Get Report

target, estimates higher at Barclays. GE price target increased to $25 from $22 after a solid 1Q10 beat. GE Capital has turned the corner. 2010 EPS estimate lifted to $1.10, 2011 held at $1.40. Reiterate Overweight rating.

General Electric

(GE) - Get Report

numbers increased at UBS. Estimates were boosted through 2011. Company had strong earnings and credit metrics are improving. Neutral rating and new $19 price target.

Goldman Sachs

(GS) - Get Report

cut from Top Picks list at FBR. GS was removed from the Top Picks list. SEC actions will hang over the stock. Outperform rating and $190 price target.

Nasdaq

I:IXIC

estimates trimmed at UBS through 2011. Company is seeing lower US cash and options volume. Neutral rating and $21 price target.

NRG Energy

(NRG) - Get Report

estimates boosted at Credit Suisse. NRG 2010 and 2011 EPS estimates raised to $1.73 and $1.12, respectively. Potential for 1Q10 upside. Reiterate Outperform rating and $30 price target.

NYSE Euronext

(NYX)

estimates lowered at UBS cut through 2011. Company is seeing weaker volumes across the board. Buy rating and $33 price target.

OSI Pharmaceuticals

(OSIP)

price target boosted at Barclays to $67 from $64 following approval of Tarceva for NSCLC. Maintain Equal Weight rating.

Visa

(V) - Get Report

target boosted at UBS to $110. Company should post strong quarterly results, given easy comparisons. Outperform rating.

This article was written by a staff member of TheStreet.com.